Upexi Inc
UPXI4.910USD
+0.140+2.94%
Fechamento 10/24, 16:00（ET）Cotações atrasadas em 15 min
187.91MValor de mercado
PerdaP/L TTM
Mais detalhes de Upexi Inc Empresa
Upexi, Inc. is a brand owner specialized in the development, manufacturing and distribution of consumer products. The Company focuses on direct-to-consumer and Amazon brands. The Company’s brands include LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, Gumi Labs, and Upexi Distribution. LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements. Gumi Labs manufactures gummies and other products supporting its health and wellness products, including those products manufactured with hemp ingredients. Upexi Distribution manages the warehousing and logistic needs of the Company and provides storage, consolidation, assembly, Amazon preparation, distribution and fulfilment services to its brands and its manufacturing operation.
Informações de Upexi Inc
Código da empresaUPXI
Nome da EmpresaUpexi Inc
Data de listagemJun 24, 2021
CEO- -
Número de funcionários64
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 24
Endereço3030 Rocky Point Drive
CidadeTAMPA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal33607
Telefone17013535425
Sitehttps://upexi.com/
Código da empresaUPXI
Data de listagemJun 24, 2021
CEO- -
Executivos da empresa Upexi Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
585.37K
+60.32%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
349.14K
+252.17%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Allan Marshall ,
Allan Marshall ,
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.51M
+899.43%
Dr. Gene Salkind, M.D.
Dr. Gene Salkind, M.D.
Independent Director
Independent Director
585.37K
+60.32%
Mr. Andrew J. Norstrud
Mr. Andrew J. Norstrud
Chief Financial Officer, Director
Chief Financial Officer, Director
349.14K
+252.17%
Mr. Thomas Charles Williams
Mr. Thomas Charles Williams
Independent Director
Independent Director
100.00K
--
Mr. Lawrence H. Dugan
Mr. Lawrence H. Dugan
Independent Director
Independent Director
--
--
Mr. Valter Pinto
Mr. Valter Pinto
Investor Relations
Investor Relations
--
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q1
Por EmpresaUSD
Nome
Receita
Proporção
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%
Por RegiãoUSD
Nome
Receita
Proporção
United States of America
14.57M
98.25%
Other
259.57K
1.75%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Internally manufactured
9.26M
62.48%
Contract manufactured
2.79M
18.80%
Purchased as finished goods
2.78M
18.73%
Distribuição de ações
Atualizado em: sáb, 18 de out
Atualizado em: sáb, 18 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
MMCAP Asset Management
21.98%
Samara Special Opportunities
7.69%
GSR Growth Investments LP
3.92%
Marshall (Allan)
2.57%
Pantera Capital Partners LP
2.26%
Outro
61.59%
Investidores
Investidores
Proporção
MMCAP Asset Management
21.98%
Samara Special Opportunities
7.69%
GSR Growth Investments LP
3.92%
Marshall (Allan)
2.57%
Pantera Capital Partners LP
2.26%
Outro
61.59%
Tipos de investidores
Investidores
Proporção
Hedge Fund
23.83%
Corporation
11.61%
Individual Investor
5.95%
Investment Advisor
5.51%
Investment Advisor/Hedge Fund
1.00%
Research Firm
0.26%
Bank and Trust
0.24%
Venture Capital
0.14%
Outro
51.45%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
53
23.37M
39.68%
+23.17M
2025Q2
46
10.18M
21.50%
+7.63M
2025Q1
42
311.78K
28.56%
-35.31K
2024Q4
42
307.62K
23.29%
-32.82K
2024Q3
40
303.51K
29.16%
-55.91K
2024Q2
40
319.39K
30.68%
-45.58K
2024Q1
42
328.34K
32.32%
-46.59K
2023Q4
42
319.26K
31.43%
-34.26K
2023Q3
40
369.15K
37.28%
-46.01K
2023Q2
44
368.80K
38.85%
-28.58K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
MMCAP Asset Management
12.94M
21.98%
+12.94M
--
Jul 16, 2025
Samara Special Opportunities
4.53M
7.69%
+4.53M
--
Aug 29, 2025
GSR Growth Investments LP
2.31M
3.92%
-1.00
-0.00%
Jun 30, 2025
Marshall (Allan)
1.51M
2.57%
+1.36M
+899.43%
Jul 16, 2025
Pantera Capital Partners LP
1.33M
2.26%
+1.33M
--
Jun 30, 2025
Rudick (Brian Benjamin)
838.60K
1.42%
+400.00K
+91.20%
Jul 16, 2025
Salkind (Gene)
585.37K
0.99%
+220.24K
+60.32%
Jul 16, 2025
NewGen Asset Management Limited
577.19K
0.98%
+577.19K
--
Jun 30, 2025
The Vanguard Group, Inc.
500.84K
0.85%
+500.84K
--
Jun 30, 2025
Kathmere Capital Management
2.19M
3.72%
+2.19M
--
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: seg, 6 de out
Atualizado em: seg, 6 de out
Nome
Proporção
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Data
Tipo
Proporção
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
Sep 27, 2024
Merger
20→1
